Horizon Therapeutics Public Limited's

• HZNP's Stock Performance relative to its Competitors

Sanofi Share Performance -3.58% Over The Past 5 Days

Sanofi Profile Sanofi's business model revolves around the development, production, and distribution of pharmaceutical products. They aim to innovate and provide healthcare solutions across various therapeutic areas to improve patients' lives worldwide. Sanofi collaborates with partners and healthcare professionals to ensure effective delivery of their products and to address evolving patient needs. More about Sanofi's Market Share

Inflarx N V Share Performance +39.12% One Year

Inflarx N V Profile Inflarx N is a company that operates on a B2B (business-to-business) model. They offer a range of services and products such as software solutions, data analytics, and consulting to businesses in the technology sector. Their revenue primarily comes from subscription fees, licensing, and consulting fees. More about Inflarx N V's Market Share

Eqrx Inc Share Performance +4.46% This Quarter

Eqrx Inc Profile Eqrx Inc is a pharmaceutical company that focuses on creating affordable and accessible medication. They employ an innovative business model that combines research and development with scientific expertise to develop generic alternatives to the high-priced drugs in the market. By bypassing the traditional pharmaceutical pricing system, Eqrx aims to make essential medications more affordable for patients and healthcare providers. More about Eqrx Inc 's Market Share

Prelude Therapeutics Inc Share Performance +29.82% This Quarter

Prelude Therapeutics Inc Profile Prelude Therapeutics Inc is a biopharmaceutical company that focuses on developing innovative small molecule therapeutic products for cancer treatment. Their business model revolves around conducting extensive research and employing a target discovery engine to identify and validate potential drug targets. By using a combination of proprietary technologies and collaborations with academic institutions, Prelude Therapeutics aims to develop and commercialize novel oncology therapies to address unmet medical needs. More about Prelude Therapeutics Inc's Market Share

Anixa Biosciences Inc Share Performance -15.99% 30 Days

Anixa Biosciences Inc Profile Anixa Biosciences Inc's business model focuses on developing and commercializing innovative diagnostics and therapeutics in the field of cancer. More about Anixa Biosciences Inc 's Market Share

Sources: Horizon Therapeutics Public Limited Company’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Thursday, September 10, 2026 4:27 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Horizon Therapeutics Public Limited Company versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.